Home Collection91115-91115

OSTEOSCREEN PANEL II

This panel tests for markers related to bone metabolism, providing insights into bone density and mineralization. It helps in maNot Applicableging and diagnosing bone disorders like osteopenia or osteoporosis.

Also known asOsteoscreen Panel Ii Osteoscreen Panel Ii

Available via

Home Collection, Lab Visit

Contains

6 parameters

Earliest reports in

Same Day

Test details

OSTEOSCREEN PANEL II Package in Vadodara Overview

Preparations

No special preparations needed

Test included
OSTEOSCREEN PANEL II includes 6 parameters

  • Calcium

  • Alkaline Phosphatase

  • Osteocalcin

  • Phosphorus

  • Pth (intact)

  • 25 - Hydroxyvitamin D
Frequently Asked Questions

Osteoscreen Panel II is a comprehensive screening test that evaluates several biomarkers associated with bone health. It is typically used to assess bone metabolism and the risk of disorders such as osteoporosis.

This panel helps in the early detection of metabolic bone diseases and in monitoring the effectiveness of treatment for conditions like osteoporosis and osteopenia.

A blood sample is taken and analyzed for specific bone turnover markers. These may include calcium, vitamin D, parathyroid hormone (PTH), and other bone-specific proteins.

Abnormal levels can indicate bone loss, poor bone formation, or metabolic imbalances. These findings guide further evaluation and treatment strategies.

Fasting may be required depending on the components of the panel. Follow your healthcare provider’s instructions.

Test code

1018

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Plasma EdtaLavender Vacutainer12 ML
SerumYellow Vacutainer3.7 ML

Specimen stability information

Plasma Edta, Serum

Collection instructions

Serum (LIPEMIC & HAEMOLYSED SAMPLE SHOULD BE AVOIDED)(R) AGE, Gender AND Clinical HISTORY IS MANDATORY + 2 Serum (F) + EDTA Plasma (F) ,Serum [Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration]+ Clinical History Serum [Samples should not be taken from patients receiving therapy with high biotin doses (i.e. > 5 mg/day) until at least 8 hours following the last biotin administration]

Specimen rejection criteria

Test run frequency

'

Turn around time

Same Day

Performing locations

Department

  • Bio Chemistry
  • Endocrinology

CPT and Loinc codes

OSTEOSCREEN PANEL II

₹5800